Moza Alishaq
- Infectious Diseases
- Molecular Medicine top 5%
- Modeling and Simulation top 5%
- Clinical Psychology
- Pulmonary and Respiratory Medicine
- Co-authors
- Andrew JeremijenkoAdeel A. ButtAbdul‐Badi Abou‐SamraHanaa Nafady‐HegoPeter CoyleAli Nizar LatifAnvar Hassan KaleeckalKarim Chamari
- Topics
- SARS-CoV-2 and COVID-19 Research (6 papers)COVID-19 epidemiological studies (5 papers)Infection Control and Ventilation (4 papers)
- Journals
- PLoS ONEBMC Public HealthMedicine
In The Last Decade
Moza Alishaq
14 papers receiving 233 citations
Peers
Comparison fields: 5 of 62
- Infectious Diseases 107
- Molecular Medicine 74
- Modeling and Simulation 50
- Clinical Psychology 50
- Pulmonary and Respiratory Medicine 39
Countries citing papers authored by Moza Alishaq
This map shows the geographic impact of Moza Alishaq's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moza Alishaq with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moza Alishaq more than expected).
Fields of papers citing papers by Moza Alishaq
This network shows the impact of papers produced by Moza Alishaq. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moza Alishaq. The network helps show where Moza Alishaq may publish in the future.
Co-authorship network of co-authors of Moza Alishaq
This figure shows the co-authorship network connecting the top 25 collaborators of Moza Alishaq. A scholar is included among the top collaborators of Moza Alishaq based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moza Alishaq. Moza Alishaq is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 2 | |
| 7 | 1 | |
| 8 | 3 | |
| 9 | 8 | |
| 10 | 8 | |
| 11 | 2 | |
| 12 | 33 | |
| 13 | 75 | |
| 14 | 0 | |
| 15 | 103 |
About Moza Alishaq
Moza Alishaq is a scholar working on Modeling and Simulation, Infectious Diseases and Pharmacy, having authored 15 papers that have together received 240 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (6 papers), COVID-19 epidemiological studies (5 papers) and Infection Control and Ventilation (4 papers). The work is most often cited by research in Molecular Medicine (74 citations), Applied Microbiology and Biotechnology (29 citations) and Modeling and Simulation (50 citations). Moza Alishaq has collaborated with scholars based in Qatar, Egypt and Malaysia. Frequent co-authors include Andrew Jeremijenko, Adeel A. Butt, Abdul‐Badi Abou‐Samra, Hanaa Nafady‐Hego, Peter Coyle, Ali Nizar Latif, Anvar Hassan Kaleeckal, Karim Chamari, Roald Bahr and Andrew Jeremijenko. Their work appears in journals such as PLoS ONE, BMC Public Health and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.